ESR1 and breast carcinoma: The luminal subtypes (A or B) account for the majority of breast cancers and are characterized by expression of hormone receptors for estrogen (estrogen receptor α, ERα) and/or progesterone (PR) with or without expression of human epidermal growth factor receptor 2 (HER2).